Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Advanced Course on Clinical Questions in Advanced Bladder and Renal Cell Carcinoma 2022

ESMO-Virtual-Advanced-Courses-advanced-badder-renal-cell-carcinoma-2022-1000x250-june
Start date
20 Jun 2022
End date
21 Jun 2022
Location
Virtual, GMT +8

Please kindly note that the virtual course programme timings are to be considered GMT+8.

Learning objectives 

  • To understand essentials in the assessment and the value of multidisciplinary management of advanced bladder and renal cell carcinoma (RCC)
  • To learn about state-of-the-art advances in treatment of advanced bladder and renal cell carcinoma
  • To learn the principles of management of advanced bladder and renal cell carcinoma through direct exposure to real clinical scenarios

Download the programme 

How to apply

Application is via online form. During the application process you will be required to upload the following:

  • Your CV including a list of your publications

Application deadline

Application deadline has now closed.

Who can apply?

While this online course is primarily aimed at experienced oncologists resident in Asia, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary registration for this virtual course.

Accreditation

The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

  • Anja Lorch, Switzerland
  • Ravindran Kanesvaran, Singapore

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.